FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327532028> ?p ?o ?g. }

• W2327532028 endingPage "45" @default.
• W2327532028 startingPage "40" @default.
• W2327532028 abstract "Disseminated carcinoma of the prostate (CaP) is a common manifestation of this disease. Metastatic CaP in the United States is seen in about 45,000 patients each year at diagnosis. At least the same number of patients who have had prior definitive treatment with surgery or radiotherapy develop evidence of metastatic disease. Hormonal management is the most important and well established treatment for patients with prostatic metastases. Orchiectomy remains the most efficient and most cost effective therapy in a rapid ablation of testicular androgens. Due to a well known psychological reaction to castration which is seen in many patients, diethylstilbestrol (DES) is a good alternative and cost effective therapy. The mode of action of DES is to suppress LH production and to slowly, indirectly, decrease serum testosterone level. In recent years, total androgen blockade (TAB) has become a widely accepted treatment option. This treatment has been shown in several clinical trials to be effective and well tolerated by the patients. A major problem with a routine use of TAB is a relatively high cost of this therapy. In a European prospective randomized trial, goserelin acetate-flutamide combination significantly increased time to progression when compared with orchiectomy alone. Patients with localized and symptomatic metastases are best treated with radiotherapy. Those with multiple sites of involvement are best treated with strontium-89 which results in a good palliation in a majority of patients. Nearly all hormonally treated patients, with metastatic CaP, eventually show tumor progression. Presently available chemotherapy is of a low effectiveness and should not be used for these patients outside of controlled clinical trials. Current research is directed to identify effective therapy for hormone refractory patients. Immunotherapy and gene therapy may be useful future therapeutic options." @default.
• W2327532028 created "2016-06-24" @default.
• W2327532028 creator A5003003402 @default.
• W2327532028 creator A5007590098 @default.
• W2327532028 creator A5028905272 @default.
• W2327532028 creator A5029849687 @default.
• W2327532028 creator A5053401288 @default.
• W2327532028 creator A5084766370 @default.
• W2327532028 date "1997-02-01" @default.
• W2327532028 modified "2023-09-30" @default.
• W2327532028 title "Treatment of Metastatic Carcinoma of the Prostate" @default.
• W2327532028 cites W116367892 @default.
• W2327532028 cites W122252942 @default.
• W2327532028 cites W1979211241 @default.
• W2327532028 cites W1983514189 @default.
• W2327532028 cites W1984749582 @default.
• W2327532028 cites W1994047807 @default.
• W2327532028 cites W1998832426 @default.
• W2327532028 cites W2006734418 @default.
• W2327532028 cites W2013614953 @default.
• W2327532028 cites W2014145760 @default.
• W2327532028 cites W2030312997 @default.
• W2327532028 cites W2035397440 @default.
• W2327532028 cites W2035831668 @default.
• W2327532028 cites W2050664130 @default.
• W2327532028 cites W2062090998 @default.
• W2327532028 cites W2070408871 @default.
• W2327532028 cites W2074544671 @default.
• W2327532028 cites W2079700809 @default.
• W2327532028 cites W2087619815 @default.
• W2327532028 cites W2092991204 @default.
• W2327532028 cites W2097037303 @default.
• W2327532028 cites W2120176830 @default.
• W2327532028 cites W2136456463 @default.
• W2327532028 cites W2156722174 @default.
• W2327532028 cites W2165631552 @default.
• W2327532028 cites W2204115562 @default.
• W2327532028 cites W2298468665 @default.
• W2327532028 cites W2401802839 @default.
• W2327532028 cites W2404117595 @default.
• W2327532028 cites W2419470907 @default.
• W2327532028 cites W2423112668 @default.
• W2327532028 cites W2498708640 @default.
• W2327532028 cites W4237630442 @default.
• W2327532028 cites W61945152 @default.
• W2327532028 cites W2078543218 @default.
• W2327532028 doi "https://doi.org/10.1097/00000421-199702000-00009" @default.
• W2327532028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9020286" @default.
• W2327532028 hasPublicationYear "1997" @default.
• W2327532028 type Work @default.
• W2327532028 sameAs 2327532028 @default.
• W2327532028 citedByCount "15" @default.
• W2327532028 countsByYear W23275320282012 @default.
• W2327532028 countsByYear W23275320282014 @default.
• W2327532028 crossrefType "journal-article" @default.
• W2327532028 hasAuthorship W2327532028A5003003402 @default.
• W2327532028 hasAuthorship W2327532028A5007590098 @default.
• W2327532028 hasAuthorship W2327532028A5028905272 @default.
• W2327532028 hasAuthorship W2327532028A5029849687 @default.
• W2327532028 hasAuthorship W2327532028A5053401288 @default.
• W2327532028 hasAuthorship W2327532028A5084766370 @default.
• W2327532028 hasConcept C121608353 @default.
• W2327532028 hasConcept C126322002 @default.
• W2327532028 hasConcept C126894567 @default.
• W2327532028 hasConcept C141071460 @default.
• W2327532028 hasConcept C143998085 @default.
• W2327532028 hasConcept C2776235491 @default.
• W2327532028 hasConcept C2776694085 @default.
• W2327532028 hasConcept C2777546739 @default.
• W2327532028 hasConcept C2778043895 @default.
• W2327532028 hasConcept C2778311097 @default.
• W2327532028 hasConcept C2778313021 @default.
• W2327532028 hasConcept C2779975986 @default.
• W2327532028 hasConcept C2780192828 @default.
• W2327532028 hasConcept C2781397067 @default.
• W2327532028 hasConcept C2781440318 @default.
• W2327532028 hasConcept C509974204 @default.
• W2327532028 hasConcept C61367390 @default.
• W2327532028 hasConcept C71315377 @default.
• W2327532028 hasConcept C71924100 @default.
• W2327532028 hasConceptScore W2327532028C121608353 @default.
• W2327532028 hasConceptScore W2327532028C126322002 @default.
• W2327532028 hasConceptScore W2327532028C126894567 @default.
• W2327532028 hasConceptScore W2327532028C141071460 @default.
• W2327532028 hasConceptScore W2327532028C143998085 @default.
• W2327532028 hasConceptScore W2327532028C2776235491 @default.
• W2327532028 hasConceptScore W2327532028C2776694085 @default.
• W2327532028 hasConceptScore W2327532028C2777546739 @default.
• W2327532028 hasConceptScore W2327532028C2778043895 @default.
• W2327532028 hasConceptScore W2327532028C2778311097 @default.
• W2327532028 hasConceptScore W2327532028C2778313021 @default.
• W2327532028 hasConceptScore W2327532028C2779975986 @default.
• W2327532028 hasConceptScore W2327532028C2780192828 @default.
• W2327532028 hasConceptScore W2327532028C2781397067 @default.
• W2327532028 hasConceptScore W2327532028C2781440318 @default.
• W2327532028 hasConceptScore W2327532028C509974204 @default.
• W2327532028 hasConceptScore W2327532028C61367390 @default.
• W2327532028 hasConceptScore W2327532028C71315377 @default.

• next